SE7709615L - Sett att framstella acylerade heterocyklylkarboxylsyror - Google Patents

Sett att framstella acylerade heterocyklylkarboxylsyror

Info

Publication number
SE7709615L
SE7709615L SE7709615A SE7709615A SE7709615L SE 7709615 L SE7709615 L SE 7709615L SE 7709615 A SE7709615 A SE 7709615A SE 7709615 A SE7709615 A SE 7709615A SE 7709615 L SE7709615 L SE 7709615L
Authority
SE
Sweden
Prior art keywords
methods
carboxylic acids
heterocyclic
free
radical
Prior art date
Application number
SE7709615A
Other languages
English (en)
Other versions
SE434397B (sv
Inventor
E Habicht
P G Ferrini
A Sallmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7709615L publication Critical patent/SE7709615L/sv
Publication of SE434397B publication Critical patent/SE434397B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
SE7709615A 1976-08-27 1977-08-26 Sett att framstella bens-acyl-bensimidazol-2-derivat SE434397B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75684A LU75684A1 (sv) 1976-08-27 1976-08-27

Publications (2)

Publication Number Publication Date
SE7709615L true SE7709615L (sv) 1978-02-28
SE434397B SE434397B (sv) 1984-07-23

Family

ID=19728336

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709615A SE434397B (sv) 1976-08-27 1977-08-26 Sett att framstella bens-acyl-bensimidazol-2-derivat

Country Status (32)

Country Link
US (3) US4141982A (sv)
JP (1) JPS5328172A (sv)
AR (6) AR224610A1 (sv)
AT (1) AT359060B (sv)
AU (1) AU517209B2 (sv)
BE (1) BE858157A (sv)
CA (1) CA1098526A (sv)
CH (8) CH631973A5 (sv)
DD (1) DD132735A5 (sv)
DE (1) DE2737462A1 (sv)
DK (1) DK381277A (sv)
ES (7) ES461906A1 (sv)
FI (1) FI68230C (sv)
FR (1) FR2362841A1 (sv)
GB (2) GB1595913A (sv)
GR (1) GR72908B (sv)
HK (1) HK93784A (sv)
HU (2) HU180700B (sv)
IE (1) IE45665B1 (sv)
IL (1) IL52820A (sv)
LU (1) LU75684A1 (sv)
MY (1) MY8500936A (sv)
NL (1) NL7709471A (sv)
NO (1) NO148488C (sv)
NZ (1) NZ185035A (sv)
OA (1) OA05753A (sv)
PL (4) PL112665B1 (sv)
PT (1) PT66947B (sv)
SE (1) SE434397B (sv)
SG (1) SG70784G (sv)
SU (7) SU882410A3 (sv)
ZA (1) ZA775182B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312873A (en) * 1978-09-29 1982-01-26 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
US4322431A (en) * 1979-02-09 1982-03-30 Ciba-Geigy Corporation Pharmaceutical preparations containing benzimidazole 2-derivatives
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
EP0277402B1 (en) * 1987-02-03 1991-09-11 W.R. Grace & Co.-Conn. Biocide
JPH04197628A (ja) * 1990-11-28 1992-07-17 Sekisui Chem Co Ltd 壁パネルの製造方法
US5216003A (en) * 1992-01-02 1993-06-01 G. D. Searle & Co. Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
FR2751649B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US9663703B2 (en) 2014-04-25 2017-05-30 James George Clements Method and compositions for enhanced oil recovery
CN109467512B (zh) * 2018-12-18 2021-06-08 苏州开元民生科技股份有限公司 一种3,4-二氨基-二苯甲酮的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB766749A (en) 1954-01-11 1957-01-23 Aschaffenburger Zellstoffwerke Benzimidazole cobalamines and process for their preparation and separation
US3318889A (en) * 1963-10-14 1967-05-09 S B Penick & Company 2-benzimidazole carbamates
DE1923481A1 (de) * 1969-05-08 1970-11-12 Hoechst Ag Verfahren zur Herstellung von Amiden und Estern der 1-Hydroxy-benzimidazol-2-carbonsaeure
NL7013343A (sv) * 1969-09-26 1971-03-30
BE759237A (fr) * 1969-11-21 1971-05-01 Montedison Spa Procede de preparation d'amides a partir de composes heterocycliques azotes
BE792402A (fr) * 1971-12-07 1973-06-07 Ciba Geigy Composes heterocycliques azotes et medicaments anthelminthiqueset antimicrobiens qui en contiennent
US4026936A (en) * 1975-08-07 1977-05-31 Hoffmann-La Roche Inc. Anthelmintic pyridine and thiazole substituted benzimidazole carbamates

Also Published As

Publication number Publication date
DD132735A5 (de) 1978-10-25
AR224610A1 (es) 1981-12-30
AT359060B (de) 1980-10-27
HU186765B (en) 1985-09-30
AU517209B2 (en) 1981-07-16
FR2362841A1 (fr) 1978-03-24
OA05753A (fr) 1981-05-31
AR227621A1 (es) 1982-11-30
CH631973A5 (de) 1982-09-15
CH637120A5 (de) 1983-07-15
ES461906A1 (es) 1978-12-01
PL112665B1 (en) 1980-10-31
PL108853B1 (en) 1980-05-31
FI68230C (fi) 1985-08-12
NO148488C (no) 1983-10-19
SG70784G (en) 1985-03-15
ES471690A1 (es) 1979-10-16
GB1595914A (en) 1981-08-19
BE858157A (fr) 1978-02-27
ATA620677A (de) 1980-03-15
PL110215B1 (en) 1980-07-31
CH632749A5 (de) 1982-10-29
IL52820A (en) 1981-02-27
US4141982A (en) 1979-02-27
JPS6231706B2 (sv) 1987-07-09
IL52820A0 (en) 1977-10-31
PT66947B (en) 1979-02-07
ES8106706A1 (es) 1981-09-01
SU831074A3 (ru) 1981-05-15
CH637121A5 (de) 1983-07-15
FI772521A (fi) 1978-02-28
LU75684A1 (sv) 1978-04-13
DE2737462A1 (de) 1978-03-02
PL105527B1 (pl) 1979-10-31
IE45665B1 (en) 1982-10-20
NL7709471A (nl) 1978-03-01
ES471686A1 (es) 1979-10-16
US4344957A (en) 1982-08-17
CH634305A5 (de) 1983-01-31
ZA775182B (en) 1978-07-26
GR72908B (sv) 1984-01-04
ES471687A1 (es) 1979-10-16
SU882410A3 (ru) 1981-11-15
SU888819A3 (ru) 1981-12-07
HU180700B (en) 1983-04-29
PL200449A1 (pl) 1978-05-22
ES471689A1 (es) 1979-10-16
ES471688A1 (es) 1979-10-16
SE434397B (sv) 1984-07-23
AR225889A1 (es) 1982-05-14
NO772962L (no) 1978-02-28
NZ185035A (en) 1981-05-29
SU745365A3 (ru) 1980-06-30
AR231536A1 (es) 1984-12-28
CH631974A5 (de) 1982-09-15
AR230990A1 (es) 1984-08-31
SU923368A3 (ru) 1982-04-23
FR2362841B1 (sv) 1981-11-20
MY8500936A (en) 1985-12-31
HK93784A (en) 1984-12-07
CH632253A5 (de) 1982-09-30
ES479189A0 (es) 1981-09-01
CA1098526A (en) 1981-03-31
AU2825577A (en) 1979-03-01
NO148488B (no) 1983-07-11
DK381277A (da) 1978-02-28
SU784766A3 (ru) 1980-11-30
PT66947A (en) 1977-09-01
CH631975A5 (de) 1982-09-15
US4213993A (en) 1980-07-22
FI68230B (fi) 1985-04-30
AR222318A1 (es) 1981-05-15
GB1595913A (en) 1981-08-19
IE45665L (en) 1978-02-27
JPS5328172A (en) 1978-03-16
SU843744A3 (ru) 1981-06-30

Similar Documents

Publication Publication Date Title
IL88848A0 (en) Immunoassays utilizing chemiluminescent esters,thioesters and amides as the labels
SE7709615L (sv) Sett att framstella acylerade heterocyklylkarboxylsyror
ES8104321A1 (es) Procedimiento para separar un derivado de alquil-cetohexopi-ranosida
ES451979A1 (es) Un metodo de preparacion de compuestos antialergicos.
SE7709733L (sv) Bensopyranderivat
EG16055A (en) Alpha-alkyl polyolefinic carboxylic acids and derivatives thereof useful in the treatment of psoriasis
DE3560258D1 (en) Norbornane and norbornene carboxylic acid amides and process for their preparation
ES381578A1 (es) Procedimiento para la preparacion de nuevos acidos ariloxi y ariltio-aceticos.
GB1547473A (en) Cephalosporin compounds
IE43830L (en) Phenylpiperidine derivatives.
ES463682A1 (es) Procedimiento de preparacion de nuevos derivados de la coen-zima b12.
GB1552099A (en) Cephalosporin analogues
AU560626B2 (en) 2-alkyl-3-substituted phenylcarbonyl-benzofurans
GB2019843A (en) N-Alkenylmoranoline derivatives
YU47723B (sh) Postupak za dobivanje derivata 2-imino-3-heterocikloalkilbenzotiazolina
ES455835A1 (es) Procedimientos para la preparacion de derivados de la pipe- ridina.
JPS5573677A (en) Thienylbenzoic acid derivative and its production
IL72681A (en) 4-alkyl-5-haloimidazole-1-carboxylic acid esters and amides,their preparation and their use as nitrification inhibitors
IE44512L (en) Halogenopregnadienes
JPS5283786A (en) 7-substituted acetamido-3-alkanoyloxymethyl-3-cephem-4-carboxylic acid , its derivative and salt
ES457406A1 (es) Metodo para producir derivados uracilo.
ES454962A2 (es) Procedimiento de obtencion de nuevos derivados del acido 7- aminocefalosporanico.
IE39567L (en) Sulphur containing heterocyclic compounds
ES429156A1 (es) Un metodo para producir derivados de acidos carboxilicos benzalicilicos
JPS5283783A (en) 7-dihalogenoalkaneamide-3-hetero cyclic thiomethyl-3-cephem-4-carboxyl ic acid derivative

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7709615-4

Effective date: 19890911

Format of ref document f/p: F